Titlebook: Cancer Prevention II; Hans-J?rg Senn,Ursula Kapp,Florian Otto Conference proceedings 2009 Springer-Verlag Berlin Heidelberg 2009 ER-negati

Chameleon

Promises and Limitations of Biomarkersd for predicting response to therapy. Ye t very few markers are brought to clinical practice, and many are not even found to be reproducible. This essay discusses chance and bias as threats to validity that can explain the huge disconnect between promise and product, along with approaches to address

Spinal-Fusion

The EPIC Study: An Updateetween diet, lifestyle and environmental factors and the incidence of cancer at various sites [1, 2]. The EPIC cohort was initiated in 1992 and has gradually grown into a multi-centre study recruiting 521,000 participants aged 35–70 years, among 23 centres in 10 European countries: Denmark, France,

–LOUS

Aprope

Saline

Cancer Prevention by Vaccination Against Hepatitis Bn papilloma virus and cervical cancer, and . and gastric cancer. The first evidence of cancer prevention by vaccination in humans was provided by HBV vaccination in infants. Chronic HBV is related to approximately 60%–90% of hepatocellular carcinomas (HCC) in adults and nearly 100% of childhood HCC

北極熊

Energy Restriction for Breast Cancer Preventionsociated with a reduction in risk of postmenopausal breast cancer. Here we summarise lifestyle changes including continuous or intermittent energy restriction and/or exercise which may be beneficial for preventing breast cancer and also potential pharmacological approaches to prevention using energy

防御

The Use of Tamoxifen and Raloxifene for the Prevention of Breast Canceren at increased risk for breast cancer to determine the relative effects on the risk of invasive breast cancer. To be eligible for participation, a woman had to be healthy with at least a 5-year predicted breast cancer risk of 1.66% based on the Gail model or a history of lobular carcinoma in situ (

美學(xué)

Finasteride

改進(jìn)